COMMUNIQUÉS West-GlobeNewswire

LENZ Therapeutics to Report Third Quarter 2025 Financial Results and Recent Corporate Highlights on November 5, 2025
29/10/2025
SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1. [...]
DEBRA Research Invests in Eliksa Therapeutics to Advance ELK-003, a Biological Eye Drop for Epidermolysis Bullosa-Related Ocular Complications
29/10/2025
The financing supports Eliksa’s clinical development of ELK-003, a biological eye drop for ocular complications in Epidermolysis bullosa (EB) patients. The ongoing pilot study in cooperation with DEBRA Chile has [...]
Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
29/10/2025
– Long-time advocate, Paris Hilton, shares her personal ADHD journey from childhood to adulthood to encourage others to speak to their healthcare provider about appropriate treatment options – STOUGHTON, Mass., Oct [...]
Turning Point of Tampa Expands Access to Mental Health Care with Launch of Virtual Intensive Outpatient Program
29/10/2025
Leading behavioral healthcare provider brings evidence-based treatment directly to patients’ homes through innovative virtual IOP Tampa, FL, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Turning Point of Tampa, a trusted behavioral [...]
Reviva to Participate in the Spartan Capital Securities Second Annual Investor Conference
29/10/2025
CUPERTINO, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet [...]
Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results
29/10/2025
SOMERSET, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Wednesday, [...]
REPEAT – MEDIA ADVISORY: Patients join Day of Action at Ontario Legislature to demand action on complaints about private clinics’ charges
29/10/2025
TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- On Wednesday October 29, patients who have been wrongfully charged for surgeries and diagnostic tests at private clinics will be joined by people from across Ontario at the [...]
Belite Bio to Participate in the Deutsche Bank ADR Virtual Investor Conference
29/10/2025
SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Belite Bio Inc (NASDAQ: BLTE) (“Belite” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal [...]
Sofwave to Participate in Upcoming November Investor Conferences
29/10/2025
SAN CLEMENTE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that management will [...]
Glucose Health, Inc. Appoints Strategic Investor Christopher J. Jemapete to Its Board of Directors
29/10/2025
BENTONVILLE, Ark., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) today announced a further strengthening of its Board of Directors with the appointment of Christopher J. Jemapete, effective today. [...]
IN8bio Expands INB-100 Phase 1 Clinical Trial with Addition of The Ohio State University as New Site
29/10/2025
NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, today announced [...]
24/7 Market News- Kraig Labs Eyes Multi-Billion-Dollar Eco-Luxury Apparel Market with Mass-Produced Spider Silk
29/10/2025
DENVER, Oct. 29, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: [...]
Hyperion Surgical Announces Completion of First-in-Human Study Using Its Ivy™ Robotic Vascular Access Platform, Achieving World’s First Robotic-Assisted IV Catheterization
29/10/2025
Novel platform combining imaging, AI, and robotics aims to enhance IV placement success rates and patient experience MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Hyperion Surgical, Inc . today announced the successful [...]
Silo Pharma Selects Alphaledger’s T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain
29/10/2025
Investment vehicle provides diversified exposure to real-world assets and expected to reduce portfolio volatility Strategic allocation aligns with Silo’s objective of generating yield while maintaining a hedge against [...]
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
29/10/2025
COPENHAGEN, Denmark, October 29, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 5.20% [...]
BONK, Inc. (Nasdaq:BNKK) Management Says Independent Research Report Concludes Company Is Positioned To Be The Premier Public Vehicle For Multi-Billion Dollar BONK Crypto Ecosystem Via Solana Blockchain
29/10/2025
The Harbinger Report Outlines The Firm's Independent Estimates For Significant Revenue Growth In The Coming Years Harbinger Research Initiates Coverage, Highlighting Powerful Dual Revenue Engine, Deflationary Asset [...]
CYIOS Corporation LLC Appoints Atlanta Capital Partners, LLC for Investor Relations
29/10/2025
MELBOURNE, Australia and PALM BEACH, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- CYIOS Corporation LLC (OTC: CYIO) (“CYIOS” or the “Company”), a Nevada-registered holding company focused on acquisitions, modernization and [...]
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025
29/10/2025
SEATTLE and VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and [...]
Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics
29/10/2025
Kennewick, WA, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) today announced enhanced cooperation with Exubrion Therapeutics to advance the use of targeted radioactive isotope technology for multiple [...]

Pages